Risk of Tuberculosis During Infliximab Therapy for Inflammatory Bowel Disease, Rheumatoid Arthritis, and Spondyloarthropathy: A Meta-Analysis
Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2016.3548
Full Text
Open PDFAbstract
Available in full text
Date
July 26, 2016
Authors
Publisher
Spandidos Publications